A Challenging Issue for both Patients and Physicians: Breaking Bad News in Oncology

A Challenging Issue for both Patients and Physicians: Breaking Bad News in Oncology

Providing the patients with negative information about diagnosis, treatment, and prognosis, in otherwords breaking bad news, is a complicated process for both the patient and the physician. The oncologists often should break the bad news to patients and their relatives. Bad news in the field of oncologyoften includes the following processes: telling the diagnosis of cancer, providing information about recurrence or metastasis according to the prognosis of the disease, saying that there is nothing left to domedically, and ultimately telling the relatives of the patient the death of the patient. A negative diagnosisor a negative improvement in prognosis should be explained to the patient (sometimes to the patient’srelative) with care, empathic and sensitive attitude because a person is emotionally vulnerable whilereceiving bad news about his/her health or health of a relative. We will focus, in this article, on the importance of breaking bad news as part of clinical practice in oncology, and we will briefly introduce theprotocols developed for the proper conduct of breaking bad news and provide information about whatthe physician should do in the process of breaking bad news by considering the basic features of breaking bad news protocols

___

  • 1. Buckman R. Breaking bad news: why is it still so difficult? Br Med J (Clin Res Ed) 1984;288 (6430):1597–9.
  • 2. Ptacek JT, Eberhardt TL. Breaking bad news. A review of the literature. JAMA 1996;276(6):496–502.
  • 3. Back T. Breaking bad news. Ethics in medicine: University of Washington School of Medicine Bioethics Web site. 2013. Access: (https://depts.washington.edu/ bhdept/ethics-medicine/bioethics-topics/detail/55.) Accessed 19 Nowember 2019.
  • 4. Alshammary SA, Hamdan AB, Tamani JC, Alshuhil A, Ratnapalan S, Alharbi M. Breaking bad news among cancer physicians. J Health Spec 2017;5(4):66–72.
  • 5. Fujimori M, Akechi T, Morita T, Inagaki M, Akizuki N, Sakano Y, et al. Preferences of cancer patients regarding the disclosure of bad news. Psychooncology 2007;16(6):573–81.
  • 6. Cantürk S. Hekim gözüyle kanserle savaş (Prof. Dr. Füsun Yarış). Sabah Gazetesi 05.08.2013.
  • 7. Bousquet G, Orri M, Winterman S, Brugière C, Verneuil L, Revah-Levy A. Breaking bad news in oncology: a metasynthesis. J Clin Oncol 2015;33(22):2437–43.
  • 8. Özkıriş A, Güleç G, Yenilmez Ç, Musmul A, Yanaş M. Hekim Tutumları Üzerine Bir Çalışma: Ölüm ve Ölümcül Hastaya Yaklaşım. Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi 2011; 24(2):89–100.
  • 9. Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: A meta-analysis. Med Care 2009;47(8):826–34.
  • 10.Sarafis P, Tsounis A, Malliarou M, Lahana E. Disclosing the truth: a dilemma between instilling hope and respecting patient autonomy in everyday clinical practice. Glob J Health Sci 2013;6(2):128–37.
  • 11.Hahne J, Liang T, Khoshnood K, Wang X, Li X. Breaking bad news about cancer in China: Concerns and conflicts faced by doctors deciding whether to inform patients. Patient Educ Couns 2019;pii:S0738-3991(19)30362–3.
  • 12. Fallowfield L, Jenkins V. Communicating sad, bad, and difficult news in medicine. Lancet 2004;363(9405):312–9.
  • 13.Berney A, Carrard V, Schmid Mast M, Bonvin R, Stiefel F, Bourquin C. Individual training at the undergraduate level to promote competence in breaking bad news in oncology. Psychooncology. 2017;26(12):2232–7.
  • 14.Ciałkowska-Rysz A, Dzierżanowski T. Personal fear of death affects the proper process of breaking bad news. Arch Med Sci 2013;9(1):127–31.
  • 15.Anuk D, Alçalar N, Kaytan Sağlam E, Bahadır G. Onkoloji alanında çalışan hekimlerin perspektifinden ölüme ilişkin tutumlar ve kötü haber verme ilişkisi. Poster Sunumu (PS-089) 13. Ulusal Radyasyon Onkolojisi Kongresi Bildiri Kitapçığ, 2018;86.
  • 16.Kübler-Ross E. On death and dying. Routledge; 1973.
  • 17.Fesci HB, Ünal S. Kanserli Hastaların Kötü Haber Almaya İlişkin Görüşleri. TAF Prev Med Bull 2011;10(3):319–26.
  • 18.Matthews T, Baken D, Ross K, Ogilvie E, Kent L. The Experiences of Patients and their Family Members when Receiving Bad News about Cancer: A Qualitative Meta-synthesis. Psychooncology 2019;28(12):2286–94.
  • 19.Buckman R, Kason Y. How to break bad news – a practical protocol for healthcare professionals. 1st ed. Toronto: University of Toronto Press; 1992.
  • 20.Baile WF1, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES-a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 2000;5(4):302–11.
  • 21.VandeKieft GK. Breaking bad news. Am Fam Physician 2001;64(12):1975–8. 22.Narayanan V, Bista B, Koshy C. “BREAKS” Protocol for Breaking Bad News. Indian J Palliat Care 2010;16(2):61–5.
  • 23.Marschollek P, Bąkowska K, Bąkowski W, Marschollek K, Tarkowski R. Oncologists and breaking bad newsFrom the informed patients’ point of view. The evaluation of the SPIKES protocol implementation. J Cancer Educ 2019;34(2):375–80.
  • 24.Kalanithi P. Son nefes havaya karışmadan. 5th ed. İstanbul: Altın Kitaplar Yayınevi; 2016.
Türk Onkoloji Dergisi-Cover
  • ISSN: 1300-7467
  • Başlangıç: 2015
  • Yayıncı: Ali Cangül
Sayıdaki Diğer Makaleler

Comparison of VMAT, Field in Field, Inverse IMRT, and Helical Tomotherapy Planning in Bilateral Synchronous Breast Cancer: A Case Study

Zedef DAĞ, Şilem ERTÜRK, Oğuzhan AYRANCIOĞLU, Fikri KURT, Ayse KUTLUHAN DOĞAN, N. Deniz ARSLAN

The Effects of Secondary Cancers on Survival in Patients with Breast, Lung and Prostate Cancer

Hakan Şat BOZCUK, Hülya KARAKILINÇ, Alparslan MERDİN

Use of miRNA as a Biomarker in Prostate Cancer and New Approaches

Elif Sibel ASLAN, Sefa ÇETİNKAYA

A Challenging Issue for both Patients and Physicians: Breaking Bad News in Oncology

Güler BAHADIR, Dilek ANUK

Alteration in Characteristics and Outcome of Pediatric Burkitt Lymphoma in Turkey: Single-center Experience

Ceyhun BOZKURT, Nazmiye YÜKSEK, Gürses ŞAHİN, Sonay İNCESOY ÖZDEMİR, Eda BALKAYA

Correlation of HER2/TOP2A Gene Aberrations with RASSF1A/APC Gene Methylation Status in High-Risk Breast Cancer

Oğuz ÇİLİNGİR, Ayşe Feyda NURSAL, Canan BAYDEMİR, Beyhan DURAK ARAS, Sevilhan ARTAN, Evrim ÇİFTCİ, Onur EROĞLU

Out of Field Breast Doses as an Undesired Consequence of Cervical Cancer Radiotherapy

Yunus SARALI, Canan KÖKSAL, Uğur AKBAŞ, Makbule TAMBAŞ, Hatice Bilge BECERİR

Analysis of Survival of the Patients with Brain Metastases from Lung Cancer according to Treatment Modalities and Prognostic Indexes

Halil SAĞINÇ, Papatya Bahar BALTALARLI

Hydrogel Spacer may Allow Prostate Re-irradiation even in Patients with Ulcerative Colitis: A Case Report

Patrizia CORNACCHIONE, Valentina LANCELLOTTA, Luca TAGLIAFERRI, Gian Carlo MATTIUCCI, Vincenzo VALENTINI, Mariangela MASSACCESI, Lucia CERVONE, Antonio PIRAS, Sebastiano MENNA, Luigi AZARİO, Maria ANTONIETTA GAMBACORTA

A Comparison between Breast-Conserving Surgery and Modified Radical Mastectomy Concerning the Female Sexual Function in Breast Cancer Patients under 50 Years of Age

Bekir Hakan BAKKAL, Özlem ELMAS, Güldeniz KARADENİZ ÇAKMAK